GECOP-MMC: phase IV randomized clinical trial to evaluate the efcacy of hyperthermic intraperitoneal chemotherapy (HIPEC) with mytomicin-C after complete surgical cytoreduction in patients with colon cancer peritoneal metastases
Academic Article
2022
- Overview
- Additional Document Info
- Otro
- Ver todos